Alterations in the intestinal microbiome and metabolic profile of patients with cirrhosis supplemented with lactulose, Clostridium butyricum, and Bifidobacterium longum infantis: a randomized placebo-controlled trial
BackgroundLiver cirrhosis is commonly accompanied by intestinal dysbiosis and metabolic defects. Many clinical trials have shown microbiota-targeting strategies represent promising interventions for managing cirrhosis and its complications. However, the influences of the intestinal metagenomes and m...
Main Authors: | Haifeng Lu, Xiaofei Zhu, Lingyun Wu, Xiaobin Lou, Xiaxia Pan, Bowen Liu, Hua Zhang, Lingxiao Zhu, Lanjuan Li, Zhongwen Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2023.1169811/full |
Similar Items
-
Differentiation of Bifidobacterium longum subspecies longum and infantis by quantitative PCR using functional gene targets
by: Blair Lawley, et al.
Published: (2017-05-01) -
Efficacy of Bifidobacterium longum alone or in multi-strain probiotic formulations during early life and beyond
by: Susan Mills, et al.
Published: (2023-12-01) -
Probiotic Characteristics of Human-Residential Bifidobacterium longum subsp. longum Strains
by: WANG Mingfang, CHEN Lilan, ZHANG Xueling, TIAN Fengwei, NI Yongqing
Published: (2024-01-01) -
Bifidobacterium longum Administration Diminishes Parasitemia and Inflammation During Plasmodium berghei Infection in Mice
by: Fitri LE, et al.
Published: (2023-03-01) -
Characterization and Exploitation of CRISPR Loci in Bifidobacterium longum
by: Claudio Hidalgo-Cantabrana, et al.
Published: (2017-09-01)